Navigation Links
Pharmasset Presents Results of 4-Week Combination Study of R7128 for the Treatment of Chronic Hepatitis C
Date:4/25/2008

percentages in a 4-week study that are similar to HCV protease inhibitors and has an encouraging short-term clinical safety profile. Longer-term studies of R7128 with Pegasys plus Copegus are needed to provide additional information about its potential to improve sustained virologic response (SVR) rates for HCV patients."

R7128 4-week Combination Study Overview

The 4-week Phase 1 combination clinical trial was a multiple center, observer-blinded, randomized and placebo-controlled study that was conducted in 50 treatment-naive patients chronically infected with HCV genotype 1. The primary objective was to assess the safety, tolerability and pharmacokinetics of R7128 in combination with Pegasys plus Copegus. The secondary objective was to evaluate the change in HCV RNA after 4 weeks of treatment.

The study investigated two oral dose levels of R7128, 500mg and 1500mg, each administered twice-daily (BID) with once-weekly injections of Pegasys plus Copegus BID. Each cohort of 25 patients was comprised of 20 patients receiving R7128 and 5 patients receiving placebo with Pegasys plus Copegus.

Antiviral Activity Summary

Placebo + R7128 500mg + R7128 1500mg +

Pegasys plus Pegasys plus Pegasys plus

Copegus Copegus Copegus

(n=10) (n=20) (n=20)

Mean Decrease in

HCV RNA (log10 IU/mL)

at 4 Weeks -2.95 -3.82 -5.12

Percentage of Patients

with Undetectable

HCV RNA (<15 IU/mL)

at 4 Weeks (RVR) 10% 30% 85%

Potent antiviral activity was demonstrated following 4 weeks of treatment with R7128 1500mg BID with Pegasys plus Copegus. These patients achieved a mean 5.12 log10 IU/mL decrease in HCV RNA and 85% (17 of 20) had undetectable
'/>"/>

SOURCE Pharmasset, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Pharmasset Reports First Fiscal Quarter 2008 Financial Results
2. Roche and Pharmasset To Present the R7128 Monotherapy Resistance Profile
3. Pharmasset Announces R7128 Achieves 85% Rapid Virologic Response in a 4-week Combination Study for the Treatment of Chronic Hepatitis C
4. Pharmasset Announces Clevudine and R7128 Presentations at HEP-DART
5. Pharmasset Commences Dosing in 28-Day Combination Study of R7128 with Pegasys(R) plus Copegus(R) for Hepatitis C
6. Pharmasset Commences Dosing in Phase 3 Registration Studies of Clevudine for HBV
7. Pharmasset Presents R7128 Phase 1 Single Ascending Dose Study in Healthy Volunteers
8. Idenix Pharmaceuticals Presents Positive Preclinical Data on HCV Programs at The Annual Meeting of The European Association for the Study of the Liver (EASL)
9. ACORN Presents Findings of Collaborative Metastatic Colorectal Cancer Research
10. Anadys Pharmaceuticals Presents Data on ANA598, a Non-Nucleoside Inhibitor of the HCV Polymerase, at the 21st International Conference on Antiviral Research
11. Kosan Presents Preclinical Data on Nuclear Export Inhibitors, Novel Anticancer Agents, at AACR
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/26/2015)... , March 26, 2015 Huntington Memorial ... Valley to perform transcatheter aortic valve replacement (TAVR), a ... is a revolutionary new way to replace an aortic ... a heart lung machine. The procedure is ... led by Azhil ( Alex) Durairaj , MD, interventional ...
(Date:3/26/2015)... and VANCOUVER, British Columbia, March 26, 2015 /PRNewswire/ ... provided a summary of clinical developments and announced ... Clinical Developments and Anticipated Near-term ... OncoGenex and Teva agreed to negotiate the termination ... OncoGenex. Negotiations of the final termination agreement are ...
(Date:3/26/2015)... -- According to a new market research ... Microwave, Cryoablation, Others), Department (Interventional Radiology, Surgery, Oncology), Application ... Global Forecasts to 2019", published by MarketsandMarkets, the Tumor ... growing at a CAGR of 11.50% by 2019. ... spread through 195 pages and in-depth TOC on "Tumor ...
Breaking Medicine Technology:Huntington Memorial Hospital Performs Groundbreaking Minimally Invasive Replacement of Heart Valves 2OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014 2OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014 3OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014 4OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014 5OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014 6OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014 7OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014 8Tumor Ablation Market Worth $462.0 Million by 2019 2Tumor Ablation Market Worth $462.0 Million by 2019 3Tumor Ablation Market Worth $462.0 Million by 2019 4
... N.J., Sept. 2 ConvaTec, a world-leading developer and ... care, announced today the introduction of a new, narrower ... Strengthening Fibers, now available in the U.S. and select ... exuding chronic and acute wounds. The new dressing, half ...
... Millennium Research Group (MRG), the global authority on medical ... will be driven by strong surgeon acceptance and adoption, ... Japanese surgeons are increasingly adopting anatomic, locking ... and Synthes, Locking Compression Plates , in order ...
Cached Medicine Technology:ConvaTec Expands AQUACEL® Dressing Product Line With Introduction of New Ribbon Dressing 2ConvaTec Expands AQUACEL® Dressing Product Line With Introduction of New Ribbon Dressing 3ConvaTec Expands AQUACEL® Dressing Product Line With Introduction of New Ribbon Dressing 4Surgeons Drive Plate and Screw Market to Over $170 Million in Japan by 2014 2
(Date:3/27/2015)... Healthpointe is proud to announce that ... now treating knee and hip joint disorders in practice ... Beach, and La Mirada. Dr. Stanley Katz specializes in ... joint disorders as well as chronic conditions such as ... his patients back to their normal lives. Many ...
(Date:3/27/2015)... NY (PRWEB) March 27, 2015 Ticket Down is ... Concert in 2015. After a phenomenal and highly successful ... "Nashville" will be going out on tour again in 2015 and ... tour gets underway on April 29th in New York City at ... at the Comerica Theatre on May 10th. , Fans of the ...
(Date:3/27/2015)... CA (PRWEB) March 27, 2015 While deep ... 2015 GPU technology conference (GTC) , the CEO of ... cancer and push the human lifespan well beyond the generally-agreed ... informatics company , is one of 12 companies recognized ... While other startups in the GTC Emerging Companies Summit ...
(Date:3/27/2015)... (PRWEB) March 27, 2015 According to ... http://www.idataresearch.com ), the plate and screw market in Europe ... the generic plate and screw segment. Price decreases are ... Despite representing almost 50% of the total European trauma ... decrease the total market value, year after year. ...
(Date:3/27/2015)... March 27, 2015 On March ... with former Detroit Lions wide receiver Herman Moore, ... educational presentation on substance abuse, treatment options and ... who attended were pastors, ministers and bishops from ... other distinguished guests. , “Our ‘Fighting Addiction Together’ ...
Breaking Medicine News(10 mins):Health News:Fellowship-Trained and Board-Certified Orthopedic Surgeon is Now Treating Knee and Hip Joint Disorders in Anaheim, California 2Health News:Fellowship-Trained and Board-Certified Orthopedic Surgeon is Now Treating Knee and Hip Joint Disorders in Anaheim, California 3Health News:Nashville Live in Concert Tickets in New York, Boston, Washington, DC, Chicago, Minneapolis, San Francisco, Los Angeles and Phoenix Now On Sale at TicketDown.com 2Health News:InSilico Medicine, Inc. Stands Out from High Tech Startups at 2015 GPU Conference 2Health News:InSilico Medicine, Inc. Stands Out from High Tech Startups at 2015 GPU Conference 3Health News:Titanium Trauma Treatment Devices in Europe Becoming More Affordable, Decreasing Market Value: Group Purchasing Further Eroding Selling Prices 2Health News:Titanium Trauma Treatment Devices in Europe Becoming More Affordable, Decreasing Market Value: Group Purchasing Further Eroding Selling Prices 3Health News:LiveToBeSober.org Hosts Conference on Substance Abuse Treatment and Recovery at Ford Field 2
... ... ... 2010 -- The International Health, Racquet & Sportsclub Association (IHRSA) and member health clubs ... America!, IHRSA’s national health promotion program. From May 3-9, participating IHRSA-member health clubs will ...
... ... 21st century leadership. James Strock,s latest book, "Serve to Lead" offers actionable strategies to ... excellence. , ... April 29, 2010 -- The first decade of the 21st century has been marked by ...
... Protecting ... 100’s of children around the world. Despite it being French Law to protect any swimming pool ... ... to all swimming pool owners to follow swimming pool legislation and not to leave pools a ...
... ... money and energy while providing cost-saving tax credits. Zen Windows offers a different replacement ... ... Windows, a respected Ohio company proudly provides its customers with quality, energy-efficient windows ...
... ... parsing component for U.S.A. issued Drivers, licenses which allows to incorporate Drivers, ... of a bar, restaurant, casino, health club or pawn shop? Or maybe ... scan IDs and monitor information about your customers or employees. Then ...
... ... team contest for members who spread the word about Medical Marijuana , ... (Vocus) April 29, 2010 -- ... today announced the Grand Prize Winner of its Digital Weed Team Contest. Natasha deBeauviser ...
Cached Medicine News:Health News:&#8220;Take Back Your Health&#8221; as Health Clubs Open Their Doors to the Public in May 2Health News:&#8220;Take Back Your Health&#8221; as Health Clubs Open Their Doors to the Public in May 3Health News:21st Century Leadership: New Book Shows Why it's Different and How it Can Transform People and Organizations 2Health News:21st Century Leadership: New Book Shows Why it's Different and How it Can Transform People and Organizations 3Health News:Du Toit & Associates Prepare to Prevent Silent Deaths by the Pool this Summer 2Health News:Zen Windows Offers Energy-Efficient Windows With 2010 Tax Credit in Ohio 2Health News:Nautilus IDScan.net Presents New Drivers' License Parsing Component, a Magic Tool for Software Developers 2Health News:Nautilus IDScan.net Presents New Drivers' License Parsing Component, a Magic Tool for Software Developers 3Health News:Nautilus IDScan.net Presents New Drivers' License Parsing Component, a Magic Tool for Software Developers 4Health News:Nautilus IDScan.net Presents New Drivers' License Parsing Component, a Magic Tool for Software Developers 5Health News:MarijuanaDoctors.com Announces Weed Team Contest Winner, Adds Additional Trip to the Cannabis Cup in Amsterdam 2Health News:MarijuanaDoctors.com Announces Weed Team Contest Winner, Adds Additional Trip to the Cannabis Cup in Amsterdam 3
... digital single plane C-arm angiography system is ... performance and an expansive range of diagnostic ... to ECG triggered. ... of the art dynamic Flat Detector technology, ...
... Meta-4 Computerized ENG utilizes a ... comprehensive nystagmus and ocular motor ... storage, data analysis and reanalysis ... data in the Meta-4 software ...
Stryker Leibinger offers a variety of different Titanium Implant Systems and special instrument sets, which enable our customers to treat a wide range of indication...
Stryker Leibinger offers a variety of different Titanium Implant Systems and special instrument sets, which enable our customers to treat a wide range of indication...
Medicine Products: